Advertisement
Advertisement

COGT

COGT logo

Cogent Biosciences, Inc. Common Stock

31.59
USD
Sponsored
+0.21
+0.67%
Jun 11, 09:50 UTC -4
Open

COGT Earnings Reports

Positive Surprise Ratio

COGT beat 14 of 33 last estimates.

42%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.57
Implied change from Q1 26 (Revenue/ EPS)
--
/
-5.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/
+7.55%

Cogent Biosciences, Inc. Common Stock earnings per share and revenue

On May 05, 2026, COGT reported earnings of -0.60 USD per share (EPS) for Q1 26, missing the estimate of -0.55 USD, resulting in a -8.77% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +0.68% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 9 analysts forecast an EPS of -0.57 USD, with revenue projected to reach -- USD, implying an decrease of -5.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
FAQ
For Q1 2026, Cogent Biosciences, Inc. Common Stock reported EPS of -$0.60, missing estimates by -8.77%, and revenue of $0.00, 0% as expectations.
The stock price moved up 0.68%, changed from $36.73 before the earnings release to $36.98 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 9 analysts, Cogent Biosciences, Inc. Common Stock is expected to report EPS of -$0.57 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement